Search

Your search keyword '"Ozyilkan, O"' showing total 211 results

Search Constraints

Start Over You searched for: Author "Ozyilkan, O" Remove constraint Author: "Ozyilkan, O"
211 results on '"Ozyilkan, O"'

Search Results

101. Attributes of cancer patients admitted to the emergency department in one year.

102. Primary extranodal non-Hodgkin's lymphoma: clinicopathological features, survival and treatment outcome in two cancer centers of southern Turkey.

103. Lack of prognostic significance of C-erbB-2 expression in low- and high- grade astrocytomas.

104. Breast cancer in octogenarian women: clinical characteristics and outcome.

105. Acute infusion reactions to chemotherapeutic drugs: a single institute experience.

106. Prevalence of thyroid dysfunction in untreated cancer patients: a cross-sectional study.

107. Effectiveness of percutaneous metal stent placement in cholangiocarcinoma patients with midterm follow-up: Single center experience.

108. Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: the Baskent University experience.

109. Rapidly progressing malignant insulinoma presented with multiple liver metastases: a case report.

110. Signet-ring cell carcinoma of the colon with leptomeningeal involvement.

111. Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.

112. Management of elderly patients with advanced non-small cell lung cancer in Turkey.

113. The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients.

114. Prognostic significance of the C-erbB-2 expression in turkish non-small cell lung cancer patients.

115. Primary renal lymphoma: report of four cases.

116. Little dose, huge toxicity: profound hematological toxicity of intrathecal methotrexate.

117. Squamous cell carcinoma of the renal pelvis.

118. Gemcitabine and cisplatin treatment of advanced-stage non-small-cell lung cancer in patients given cisplatin on day 8.

119. Signet-ring cell carcinoma of the gallbladder: a case report.

120. Lack of influence of cyclooxygenese-2 expression in hepatocellular carcinomas on patient survival.

121. Prostate small cell carcinoma and skin metastases: a rare entity.

122. Incidental papillary microcarcinoma of the thyroid.

123. Cancer cachexia: pathophysiologic aspects and treatment options.

124. Early diagnosis of cancer in renal transplant patients: a single center experience.

125. Gallbladder adenosquamous cell carcinoma: report of two cases.

126. Primary squamous cell carcinoma of the stomach: a case report.

127. Multiple myeloma with pleural involvement: a case report.

128. Hodgkin's disease in an elderly patient with B-cell chronic lymphocytic leukemia.

129. Controversy in folinic acid administration after fluorouracil.

130. MALTOMA presenting with thrombocytopenia.

131. Olive: fruit of peace against cancer.

132. Metastatic cerebellar medulloblastoma in the liver mimicking a complicated cyst: sonographic and MDCT findings.

133. Acute interstitial pneumopathy associated with docetaxel hypersensitivity.

134. Acute myeloid leukemia 4 years after Kaposi's sarcoma in a renal transplant recipient.

135. Appendicular metastasis from pancreatic adenocarcinoma.

136. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.

137. Dermatomyositis-like eruption after long-term hydroxyurea therapy for polycythemia vera.

141. Tamoxifen-induced cirrhotic process.

142. CA 15-3, ceruloplasmin and tissue polypeptide specific antigen as a tumour marker panel in breast cancer.

144. Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.

145. VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomas.

146. Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer.

147. Phase II trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin's lymphomas.

148. The impact of diagnosis and treatment on the quality of life in breast cancer patients.

Catalog

Books, media, physical & digital resources